PTC Therapeutics Inc

PTC Therapeutics Inc

PTCT

Market Cap$4B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
PTC Therapeutics IncPTC Therapeutics Inc-8.8-43%4.9-0.4
$55.00

Target Price by Analysts

11.2% upsidePTC Therapeutics Target Price DetailsTarget Price
$29.89

Current Fair Value

39.5% downside

Overvalued by 39.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$4.00 Billion
Enterprise Value$3.87 Billion
Dividend Yield$0 (0%)
Earnings per Share$-8.37
Beta0.63
Outstanding Shares76,925,523

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-8.8
PEG44.44
Price to Sales4.94
Price to Book Ratio-3.53
Enterprise Value to Revenue4.61
Enterprise Value to EBIT-28.22
Enterprise Value to Net Income-9
Total Debt to Enterprise0.1
Debt to Equity-0.38

Revenue Sources

No data

Insider Trades

ESG Score

No data

About PTC Therapeutics Inc

CEO: Stuart Peltz